ScholarIQanswers from OpenAlex

The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines

PaperCitations, authors & open-access status

The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines have?

ScholarIQcitation count

The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines has 46 citations in the OpenAlex counts ScholarIQ stores.

When was The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines published?

ScholarIQyear

The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines has 2008 year in the ScholarIQ index.

What is the open-access status of The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines?

ScholarIQoa status

The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines has closed oa status in the ScholarIQ index.

What is the DOI of The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines?

ScholarIQdoi

The DOI for The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines is on the source record.

What is the PMID of The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines?

ScholarIQpmid

The PMID for The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines is on the source record.

What is the OpenAlex record for The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines?

ScholarIQopenalex

The OpenAlex for The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial